United States · FDA National Drug Code directory
COSENTYX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0639_53e23ae2-ecfb-4322-8e42-cc9a2d71bcb9
- Product NDC
- 0078-0639
- Form
- INJECTION
- Composition / generic term
- secukinumab
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150121
- Source listing expiry
- 20271231
Source-listed ingredients
- SECUKINUMAB — 150 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 mL in 1 CARTON (0078-0639-41) · 0078-0639-41
- 1 mL in 1 CARTON (0078-0639-68) · 0078-0639-68
- 1 mL in 1 CARTON (0078-0639-97) · 0078-0639-97
- 2 mL in 1 CARTON (0078-0639-98) · 0078-0639-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →